Article
Immunohistochemical Detection of NRASQ61R Mutation in Diverse Tumor Types.
American journal of clinical pathology - 1 Jan 2016
Dias-Santagata Dora, Su Yuhua, Hoang Mai P
Abstract excerpt
OBJECTIVES: Testing for NRAS mutation at codon Q61 is of therapeutic, prognostic, and diagnostic importance for metastatic melanoma, thyroid carcinoma, and colorectal carcinoma. Immunohistochemistry for NRASQ61R, the most common NRAS mutation, offers several practical advantages over current molecular diagnostic techniques. METHODS: We investigated the sensitivity and specificity of NRASQ61R in a series of 149...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
